AMELIA CATHERINE NORMAN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Women's Health NASHVILLE, TN NPI 1760047534
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Women's Health TN Salix Pharmaceuticals, a division of Bausch Health US, LLC All categories
General Payments — all program years on this page
$1,312.43
- Category: General Payments
- Program years: PY2022–2024
- Record count: 51
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $745.74 across 27 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $745.74 | 27 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $121.00 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.78 | 2 |
| Daiichi Sankyo Inc. | $55.06 | 2 |
| Acerta Pharma LLC | $48.09 | 2 |
| Alexion Pharmaceuticals, Inc. | $43.80 | 2 |
| GENZYME CORPORATION | $33.93 | 1 |
| ABBVIE INC. | $32.25 | 2 |
| Merck Sharp & Dohme Corporation | $30.59 | 1 |
| Ipsen Biopharmaceuticals, Inc | $30.17 | 1 |
| EISAI INC. | $29.86 | 1 |
| Astellas Pharma US Inc | $28.53 | 1 |
| Janssen Biotech, Inc. | $28.44 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $23.93 | 1 |
| ADC Therapeutics America, Inc. | $22.14 | 1 |
| EMD Serono, Inc. | $22.04 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.94 | 1 |
| Lilly USA, LLC | $21.36 | 1 |
| JAZZ PHARMACEUTICALS INC. | $20.51 | 1 |
| PFIZER INC. | $19.90 | 1 |
| TerSera Therapeutics LLC | $17.29 | 1 |
| ARRAY BIOPHARMA INC | $17.26 | 1 |
| TAIHO ONCOLOGY, INC. | $13.87 | 1 |
By program year
Records — PY2024 (27)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.